CASP3 and breast carcinoma: The efficacy of panobinostat was spatially correlated with multiple gene expressions, including galectin-3, cleaved caspase-3, PD-L1, neuropilin-1 and calrecticulin in breast cancer, suggesting that panobinostat (80).